Icu Medical Inc/de
A maker of infusion therapy and IV safety products headquartered in San Clemente, California, ICU Medical produces the Plum family of infusion pumps, needle-free connectors like the MicroClave, and IV sets used by hospitals and clinics around the world. Physician Dr. George "Doc" Lopez founded the company in 1984 after inventing a device to better secure intravenous lines; the name comes from the Intensive Care Unit. Its best-known invention is the Clave needleless connector, which lets staff connect syringes and IV lines without ever touching a needle.
Sold 830.0K
Sold 830.0K
Granted 186.7K · Bought 37.8K · Sold 3.35M
Granted 922.4K · Bought 51.9K · Sold 576.4K
Granted 63.8K · Sold 15.8K
Granted 42.8K · Sold 54.6K
Granted 28.7K · Sold 9.0K
Granted 102.0K · Sold 29.4K
Granted 27.3K · Bought 583 · Sold 259.6K
Granted 13.0K · Bought 2.1K · Sold 201.5K
Bought 965
Granted 3.8K · Bought 2.0K · Sold 110.0K
Granted 13.7K · Sold 21.6K
Granted 11.3K · Sold 5.8K
Granted 6.0K
Granted 4.8K
Granted 6.0K
Granted 4.5K
Granted 4.3K · Sold 53.4K
Granted 19.8K · Sold 143.8K
Granted 13.4K · Bought 1.2K · Sold 5.3K
Sold 3.20M
Granted 16.9K · Bought 1.0K · Sold 317.5K
Granted 240.9K · Sold 101.3K
Granted 4.5K · Bought 765 · Sold 74.1K
Granted 4.0K · Sold 67.9K
Granted 3.7K · Sold 39.3K
Granted 14.4K · Sold 31.8K
Granted 18.5K · Sold 4.0K
Granted 146.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Smiths Group PLCFormer 10% Owner · 1 transaction | — | 1.67Mas of Feb 2024 | — | — | 830.0K |
| Smiths Group International Holdings LtdFormer 10% Owner · 1 transaction | — | 1.67Mas of Feb 2024 | — | — | 830.0K |
| Lopez George ADirector · 2452 transactions | — | 1.20Mas of Mar 2024 | 186.7K | 37.8K | 3.35M |
| Jain VivekChairman and CEO, Director · 208 transactions | — | 371.2K | 922.4K | 51.9K | 576.4K |
| Woolson DanielPresident · 64 transactions | — | 22.5K | 63.8K | — | 15.8K |
| Swinney Robert SDirector · 93 transactions | — | 21.9Kas of Sep 2021 | 42.8K | — | 54.6K |
| Brown JackDirector · 30 transactions | — | 20.3Kas of Oct 2015 | 28.7K | — | 9.0K |
| Sanzone Virginia RuthVP, General Counsel · 94 transactions | — | 19.5K | 102.0K | — | 29.4K |
| Lamb Scott EChief Financial Officer, · 91 transactions | — | 16.3Kas of Feb 2020 | 27.3K | 583 | 259.6K |
| Costello Richard AVice President Sales · 130 transactions | — | 12.9Kas of Feb 2014 | 13.0K | 2.1K | 201.5K |
| Obrien Francis JChief Financial Officer · 1 transaction | — | 8.9Kas of Feb 2008 | — | 965 | — |
| Brummett Burcar AlisonVice President Product Develop · 50 transactions | — | 1.9Kas of Feb 2014 | 3.8K | 2.0K | 110.0K |
| McGrody Kevin JChief Accounting Officer · 62 transactions | — | 1.7Kas of Mar 2022 | 13.7K | — | 21.6K |
| Finney Elisha WDirector · 21 transactions | — | 1.5K | 11.3K | — | 5.8K |
| Abbey DonaldDirector · 9 transactions | — | 1.5K | 6.0K | — | — |
| Hernandez LaurieDirector · 5 transactions | — | 1.5K | 4.8K | — | — |
| Hoffmeister David FDirector · 8 transactions | — | 1.5K | 6.0K | — | — |
| Kennedy Kolleen TDirector · 5 transactions | — | 1.5K | 4.5K | — | — |
| Connors John JDirector · 39 transactions | — | 792as of Jun 2015 | 4.3K | — | 53.4K |
| Burcar Alison DVice President and Gen'l Mgr. · 78 transactions | — | 512as of Mar 2019 | 19.8K | — | 143.8K |
| Greenberg David C.Director · 19 transactions | — | 500 | 13.4K | 1.2K | 5.3K |
| C.P. Pharmaceuticals International C.V. +3 co-filersSee Note (1), Director · 2 transactions | — | 0as of Nov 2018 | — | — | 3.20M |
| Riggs StevenVP Operations · 135 transactions | — | 0as of Feb 2018 | 16.9K | 1.0K | 317.5K |
| Voigtlander Christian B.Chief Operating Officer · 98 transactions | — | 0 | 240.9K | — | 101.3K |
| Saucedo Joseph RDirector · 79 transactions | — | 0as of May 2018 | 4.5K | 765 | 74.1K |
| Sherman Richard MDDirector · 56 transactions | — | 0as of May 2017 | 4.0K | — | 67.9K |
| Kovalchik Michael TDirector · 45 transactions | — | 0as of May 2014 | 3.7K | — | 39.3K |
| McCall Thomas DVice President and Gen'l Mgr. · 40 transactions | — | 0as of Jan 2020 | 14.4K | — | 31.8K |
| Sousa BenChief Information Officer · 24 transactions | — | 0 | 18.5K | — | 4.0K |
| Bonnell Brian MichaelChief Financial Officer · 42 transactions | — | 0 | 146.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -10.24M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.